High Stathmin expression has been associated with human malignancies such as human breast cancer, non-small cell lung cancer, human hepatoma and gastric cancer, and confirms the notion that Stathmin contributes to poor prognosis and cancer progression in tumor patients [26−31]. Here, STMN1 is linked to hepatocellular carcinoma.